Table 2.
Taxonomic Group | Abundance Status | log2 Fold Change | Adjusted p-Value |
---|---|---|---|
p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales; f__[Barnesiellaceae] | Higher in psoriatic patients with CVD | −23.34886701 | 1.05 × 10−12 |
p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; g__Coprococcus | Higher in psoriatic patients with CVD | −22.4934482 | 7.37 × 10−12 |
p__Firmicutes; c__Clostridia; o__Clostridiales; f__Veillonellaceae; g__Phascolarctobacterium | Higher in psoriatic patients with CVD | −23.97162303 | 2.65 × 10−15 |
p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales; f__Bacteroidaceae; g__Bacteroides; s__ovatus | Higher in psoriatic patients with CVD | −22.82969217 | 5.42 × 10−13 |
p__Firmicutes; c__Clostridia; o__Clostridiales | Higher in psoriatic patients without CVD | 23.26865584 | 9.73 × 10−13 |
p__Bacteroidetes; c__Bacteroidia; o__Bacteroidales; f__Rikenellaceae; g__Alistipes; s__finegoldii | Higher in psoriatic patients without CVD | 23.55698273 | 5.42 × 10−13 |
p__Firmicutes; c__Clostridia; o__Clostridiales; f__Lachnospiraceae; g__Roseburia; s__faecis | Higher in psoriatic patients without CVD | 23.62161748 | 5.42 × 10−13 |
CVD: cardiovascular disease.